source
- Gate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platformEli Lilly has been pushing at an open door by tacking on $870 million in biobucks to its existing collaboration with Gate Bioscience.
- Pharmacist urges law to modernize 340B discounts for multi-use orphan drugsA pharmacist argues that current legislation lags behind the evolving use of orphan-designated medicines, many of which now serve multiple therapeutic indications. The piece highlights the 340B dr…